Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
IEM 1754 is an AMPA receptor antagonist.1 It inhibits inward currents in whole-cell patch-clamp assays using X. laevis oocytes (IC50 = 6 µM). IEM 1754 (0.5 or 3 mg/kg) inhibits kainate-induced tonic-clonic seizures and reduces mortality in mice.2 It increases movement activity but does not reduce freezing time in a mouse model of centrifugation-induced dyskinesia when administered at a dose of 5 mg/kg.3
WARNING This product is not for human or veterinary use.
1. Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives. J. Physiol. 505(Pt 3), 655-663 (1997).
2. Combined blockade of α3β4 nicotinic acetylcholine receptors and GluR1 AMPA receptors in rats prevents kainate-
3. The involvement of glutamatergic transmission in the mechanism of movement disorders induced by reversive rotation of white mice. Neurosci. Behav. Physiol. 30(5), 543-546 (2000).